Plasma fCh levels are closely related to the grade of liver steatosis and fibrosis, and predict NASH severity. Plasma fCh levels are therefore a potential diagnostic marker for early-stage NASH in clinical practice.
No takes yet. Share an insight, caveat, or question.
Imajo et al. (2012) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: